Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is
responsible for the outbreak of coronavirus disease 19 (COVID-19) and was first identified in …

Context.—An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …

Many patients with SARS-CoV-2 infection develop neurological signs and symptoms;
although, to date, little evidence exists that primary infection of the brain is a significant …

SARS-CoV-2 infection produces neuroinflammation as well as neurological, cognitive (ie,
brain fog), and neuropsychiatric symptoms (eg, depression, anxiety), which can persist for …

Encephalopathy and encephalitis are major and devastating severe acute respiratory
syndrome coronavirus‐2 (SARS‐CoV‐2) virus‐associated central nervous system …

Objective We sought to review the literature on cerebrospinal fluid (CSF) testing in patients
with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2. Methods We performed …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human
coronavirus that has sparked a global pandemic of the coronavirus disease of 2019 (COVID …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic. Although COVID-19 …

Neurological manifestations are a significant complication of coronavirus disease (COVID-
19), but underlying mechanisms aren't well understood. The development of animal models …

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) predominantly
infects the respiratory system, several investigations have shown the involvement of the …